The TSX Venture Exchange has accepted for filing documentation with respect to the arm's-length disposition of Flurotest Diagnostic Systems Ltd., a wholly owned subsidiary of the company, for cash consideration of $1. The transaction was completed, effective Dec. 31, 2022.

For further details, please refer to the company's news release dated Jan. 3, 2023.